<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31168">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02700945</url>
  </required_header>
  <id_info>
    <org_study_id>Stroke AF</org_study_id>
    <nct_id>NCT02700945</nct_id>
  </id_info>
  <brief_title>Stroke AF - Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin</brief_title>
  <official_title>Stroke AF - Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the Stroke AF study is to compare the incidence of atrial fibrillation (AF)
      through 12 months between continuous cardiac rhythm monitoring with the Reveal LINQ™
      Insertable Cardiac Monitor (ICM) (continuous monitoring arm) and standard of care (SoC)
      medical treatment (control arm) in subjects with a recent ischemic stroke of presumed known
      origin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke AF is a prospective, multi-site, randomized, controlled, non-blinded, post-market
      study. The Stroke AF study will compare the incidence rate of atrial fibrillation through 12
      months between the continuous monitoring arm and the control arm in subjects with a recent
      ischemic stroke of presumed known origin. Subjects randomized to the continuous monitoring
      arm will have a Reveal LINQ Insertable Cardiac Monitor inserted within 10 days of the
      qualifying stroke and undergo continuous remote monitoring. Subjects randomized to the
      control arm will be followed per site specific standard of care.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of atrial fibrillation through 12 months.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of atrial fibrillation through the duration of study follow-up between study arms.</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">496</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Continuous Monitoring Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to the continuous monitoring arm will have a Reveal LINQ Insertable Cardiac Monitor inserted.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects randomized to the control arm will be followed per site specific standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Reveal LINQ™ Insertable Cardiac Monitor</intervention_name>
    <description>The Medtronic Reveal LINQ ICM is a programmable device that continuously monitors a patient's ECG (electrocardiogram) and other physiological parameters. The device records cardiac information in response to automatically detected arrhythmias and patient activation.</description>
    <arm_group_label>Continuous Monitoring Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has had an ischemic stroke believed to be due to small vessel disease, large
             vessel cervical or intracranial atherosclerosis within the past 10 days

          -  Subject is willing and able to undergo study requirements and expected to be
             geographically stable during study follow-up

          -  Subject is 60 years of age or older, or age 50 to 59 years plus a documented medical
             history of at least one of the following additional risk factors for stroke:

               -  Congestive heart failure

               -  Hypertension (Systolic Blood Pressure &gt; 140)

               -  Diabetes Mellitus

               -  Prior Stroke (&gt;90 days ago, other than study qualifying index event)

               -  Vascular disease (e.g. coronary artery disease, heart attack, peripheral artery
                  disease and complex aortic plaque)

        Exclusion Criteria:

          -  Subject has had a cryptogenic stroke

          -  Subject has had a cardioembolic stroke

          -  Subject has untreated hyperthyroidism

          -  Subject has had a recent myocardial infarction &lt;1 month of stroke

          -  Subject has had a recent cardiac surgery (e.g. coronary artery bypass surgery (CABG))
             &lt;1 month of stroke

          -  Subject has a mechanical heart valve

          -  Subject has valvular disease requiring immediate surgical intervention

          -  Subject has documented prior history of atrial fibrillation or atrial flutter

          -  Subject has permanent indication for oral anticoagulation

          -  Subject has permanent contraindication to oral anticoagulation such that detection of
             AF would not change medical management, based on enrolling investigators judgment

          -  Subject is enrolled in a concurrent study that may confound the results of this
             study. Co-enrollment in any concurrent clinical study (including registries) requires
             approval of the study manager or designee.

          -  Subject's life expectancy is less than 1 year

          -  Subject is pregnant

          -  Subject has or is indicated for implant with a pacemaker, Implantable Cardioverter
             Defibrillator (ICD), Cardiac ResynchronizationTherapy (CRT), or an implantable
             hemodynamic monitor

          -  Subject with a medical condition that precludes the patient from participation in the
             opinion of the investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Innovative Medical Research</name>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <zip>33180</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Kreger</last_name>
      <phone>305-918-0505</phone>
      <email>howiekreger@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Hospital Neuroscience Institute</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Indrani Acosta</last_name>
      <phone>407-215-4957</phone>
      <email>acostaindi@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611-5928</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Bernstein</last_name>
      <phone>312-695-7950</phone>
      <email>r-bernstein@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Health Lexington</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503-1450</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Curtis Given</last_name>
      <email>Curtis.given@bhsi.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Norton Neuroscience Institute</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadeem Talpur</last_name>
      <phone>502-394-6460</phone>
      <email>nadeem.talpur@nortonhealthcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medtronic, Inc</name>
      <address>
        <city>Mounds View</city>
        <state>Minnesota</state>
        <zip>55112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer L Heim</last_name>
      <phone>763-526-3553</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Clinic Cardiology</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Rempe</last_name>
      <phone>314-251-6075</phone>
      <email>david.rempe@mercy.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University at Buffalo, The State University of New York</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashkan Mowla</last_name>
      <phone>716-859-7615</phone>
      <email>mowla@buffalo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016-6402</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koto Ishida</last_name>
      <phone>212-263-7744</phone>
      <email>Koto.ishida@nyumc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mandip Dhamoon</last_name>
      <phone>212-241-2252</phone>
      <email>mandip.dhamoon@mssm.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Overlook Medical Center</name>
      <address>
        <city>Summit</city>
        <state>New York</state>
        <zip>07901-3533</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Felberg</last_name>
      <phone>908-522-4983</phone>
      <email>robert.felberg@atlantichealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LeBauer Cardiovascular Research Foundation</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pramod Sethi</last_name>
      <phone>336-273-2511</phone>
      <email>pramod.sethi@conehealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Scared Heart</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <zip>97477-8800</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elaine Skalabrin</last_name>
      <phone>541-912-6653</phone>
      <email>eskalabrin@peacehealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lankenau Institute for Medical Research</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucas Margolies</last_name>
      <email>lzm76@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Thomas Research Institute</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franke LaFranchise</last_name>
      <phone>615-222-3831</phone>
      <email>frank.Lafranchise@sth.org</email>
    </contact>
    <investigator>
      <last_name>Franke LaFranchise</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dion Graybeal</last_name>
      <phone>214-820-4561</phone>
      <email>dion.graybeal@baylorhealth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas (UT) Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Johnson</last_name>
      <phone>214-648-3748</phone>
      <email>Mark.Johnson@UTSouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030-2703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Volpi</last_name>
      <phone>713-441-3780</phone>
      <email>jjvolpi@houstonmethodist.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centra Medical Group Stroobants Cardiovascular Center</name>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <zip>24501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Sackett</last_name>
      <phone>434-200-2727</phone>
      <email>matthew.sackett@centrahealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Saint Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khaled Asi</last_name>
      <phone>414-385-4638</phone>
      <email>khaled.asi@aurora.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 8, 2016</lastchanged_date>
  <firstreceived_date>March 2, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
